Bedside Sleep Medicine

Intensive Cared Bedside Sleep Medicine

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01924507

Enrollment

400

Registered

2013-08-16

Start date

2013-08-31

Completion date

2015-12-31

Last updated

2013-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Decompensated Heart Failure, Acute Myocardial Infarction, Sleep Apnea, Sleep Disorders

Keywords

Sleep medicine, Sleep apnea, Acute myocardial infarction, Heart failure, CPAP

Brief summary

The investigators aimed to evaluated the role of bedside sleep medicine in an cardiology intensive care unit. The patients will be submitted to a overnight polysomnography. Those individuals with sleep apnea will be treated with CPAP during the ICU admission. Also, the investigators will identify the factors that compromise the sleep and will act to minimize them to improve the sleep quality. After the interventions, the investigators will evaluate if there are reduced days of hospital admission, major cardiovascular events (infarction, reinfarction, heart failure and stroke) and overall mortality.

Detailed description

At the hospital discharge and after at 1, 3 and 12 months we will evaluate the occurrence of major cardiovascular events (infarction, reinfarction, heart failure and stroke) and overall mortality.

Interventions

DEVICECPAP

CPAP - continuous positive air pressure in patients with sleep apnea

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Acute myocardial infarction * Acute decompensated heart failure * Age \> 18 years-old * Cardiology intensive care unit admission

Exclusion criteria

* Intravenous sedation * Invasive mechanical ventilation * hemodynamic instability * use of intravenous vasoactive drugs * acute respiratory failure

Design outcomes

Primary

Measure	Time frame	Description
days of admission	7 days	Days of admission in the cardiology intensive care unit

Secondary

Measure	Time frame
Combination of acute myocardial infarction, reinfarction, heart failure and stroke	12 months

Other

Measure	Time frame
Overall mortality	12 months

Countries

Brazil

Contacts

Primary ContactFatima Cintra, MD, PhD

fatimacintra@interair.com.br55-11-55764618

Backup ContactLuciana Storti Mancuso, BSN

ljstorti@hotmail.com55-11-55764230

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026